Highlights CureVac

Stocks

CVAC

NL0015436031

Market Closed - Nasdaq Other stock markets 04:00:00 2026-01-05 pm EST			5-day change	1st Jan Change
4.660 ^USD	-0.21%		-.--%	+3.10%

Apr. 15	Evotec Taps CureVac Executive as COO	MT
Jan. 06	CureVac ends coverage after BioNTech acquisition

Highlights

Jan. 06	CureVac ends coverage after BioNTech acquisition
Dec. 18	BioNTech SE completed the acquisition of CureVac N.V. from dievini Hopp BioTech holding GmbH & Co. KG, KfW and others.	CI
Dec. 18	BioNTech Closes CureVac Acquisition	MT
Dec. 18	Biontech closes acquisition of CureVac	RE
Dec. 03	Biontech achieves minimum condition in CureVac exchange offer	RE
Nov. 25	CureVac acquisition advances as cash runway secured to 2028
Nov. 24	CureVac N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
Nov. 24	CureVac Q3 Earnings, Revenue Fall	MT
Nov. 24	Earnings Flash (CVAC) CureVac Posts Q3 Revenue 54.1M Euros	MT
Nov. 24	Earnings Flash (CVAC) CureVac Posts Q3 EPS 1.21 Euros	MT
25-10-22	BioNTech Initiates $1.25 Billion Public Exchange Offer for CureVac	MT
25-10-22	Biontech commences public exchange offer for all outstanding shares of CureVac N.V.	RE
25-08-18	CureVac: Despite weak Q2, acquisition remains on track
25-08-15	CureVac N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
25-08-15	CureVac's Q2 Pre-Tax Loss Narrows, Revenue Falls	MT
25-08-15	Earnings Flash (CVAC) CureVac Posts Q2 Revenue 1.2M Euros, vs. FactSet Est of 3.3M Euros	MT
25-06-12	Top Midday Gainers	MT
25-06-12	BioNTech to Acquire CureVac in $1.25 Billion All-Stock Deal	MT
25-06-12	BioNTech SE entered into a definitive Purchase Agreement to acquire CureVac N.V. from dievini Hopp BioTech holding GmbH & Co. KG, Qatar Holding LLC, KfW and others for $1.3 billion.	CI
25-06-12	Top Premarket Gainers	MT
25-06-12	BioNTech to Buy CureVac in All-Stock Deal	MT
25-06-12	Biontech Announces Strategic Transaction To Acquire Curevac In Public Exchange Offer	RE
25-05-20	CureVac N.V. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-05-20	Curevac Q1 Revenue Eur 900 Thousand	RE
25-04-11	CureVac: 2025 will be less costly